End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 CNY | +4.91% | +2.62% | -17.25% |
04-15 | Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | Biocause Pharma’s Insurance Unit Posts Steady Annual Premium in 2023 | MT |
Chart calendar Hubei Biocause Pharmaceutical Co., Ltd.
Upcoming events on Hubei Biocause Pharmaceutical Co., Ltd.
Past events on Hubei Biocause Pharmaceutical Co., Ltd.
2024-01-29 01:00 | Extraordinary Shareholders Meeting |
2023-10-30 | Q3 2023 Earnings Release |
2023-08-30 | Q2 2023 Earnings Release |
2023-05-19 02:00 | Annual General Meeting |
2023-04-27 | Q1 2023 Earnings Release |
2022-12-23 01:00 | Extraordinary Shareholders Meeting |
2022-10-28 | Q3 2022 Earnings Release |
2022-08-29 | Interim 2022 Earnings Release |
2022-05-23 02:00 | Annual General Meeting |
2022-04-29 | Q1 2022 Earnings Release |
2022-04-29 | FY 2021 Earnings Release |
2021-10-29 | Q3 2021 Earnings Release |
2021-08-30 | Interim 2021 Earnings Release |
2021-08-20 02:00 | Extraordinary Shareholders Meeting |
2021-05-21 02:00 | Annual General Meeting |
2021-04-29 | Q1 2021 Earnings Release |
2021-04-29 | FY 2020 Earnings Release |
2021-01-25 01:00 | Extraordinary Shareholders Meeting |
2020-10-30 | Q3 2020 Earnings Release |
2020-09-24 | Extraordinary Shareholders Meeting |
Past dividends on Hubei Biocause Pharmaceutical Co., Ltd.
2023-05-29 | Annual 0.11 CNY |
2022-06-01 | Annual 0.005 CNY |
2021-06-03 | Annual 0.01 CNY |
2020-05-19 | Final Payment 0.1 CNY |
2019-09-25 | Interim Payment 0.03 CNY |
2018-10-11 | Interim Payment 0.03 CNY |
2018-06-07 | Annual 0.01 CNY |
2017-06-20 | Annual 0.025 CNY |
2016-04-13 | Annual 0.009534 CNY |
Annual results
Fiscal Period | December | 2019 | 2022 |
---|---|---|---|
Net sales | Released Forecast Spread | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
EBIT | Released Forecast Spread | 0,00 | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 |
Net income Million CNY | Released Forecast Spread | 1 776 | 274 |
EPS CNY | Released Forecast Spread | 0,36 | 0,06 |
Announcement Date | 14/04/20 | 14/04/23 |
Past sector events for Hubei Biocause Pharmaceutical Co., Ltd.
2024-04-23 | RAY SIGORTA ANONIM SIRKETI: Q1 2024 Earnings Release (Projected) |
2024-04-10 05:37 | CATHAY FINANCIAL HOLDING CO., LTD.: March 2024 Sales and Revenue Release |
2024-04-04 23:34 | PT SINAR MAS MULTIARTHA TBK: Q4 2023 Earnings Release |
2024-03-28 03:00 | CHESNARA PLC: Q4 2023 Earnings Release |
2024-03-27 16:48 | THE PHOENIX HOLDINGS LTD.: Q4 2023 Earnings Release |
2024-03-27 06:30 | WÜSTENROT & WÜRTTEMBERGISCHE AG: Q4 2023 Earnings Release |
2024-03-27 05:36 | NEW CHINA LIFE INSURANCE COMPANY LTD.: Q4 2023 Earnings Release |
2024-03-27 01:10 | MOMENTUM METROPOLITAN HOLDINGS LIMITED: Q2 2024 Earnings Release |
2024-03-27 01:05 | OLD MUTUAL LIMITED: Q4 2023 Earnings Release |
2024-03-25 | INVERSIONES LA CONSTRUCCIÓN S.A.: Q4 2023 Earnings Release |
Annual profits - Rate of surprise
- Stock Market
- Equities
- 000627 Stock
- Calendar Hubei Biocause Pharmaceutical Co., Ltd.